These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17971853)

  • 21. Characterization of
    Tacoli C; Gai PP; Siegert K; Wedam J; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Gai P; Devi R; Mockenhaupt FP
    Am J Trop Med Hyg; 2019 Aug; 101(2):416-417. PubMed ID: 31218998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon.
    Silva SR; Almeida ACG; da Silva GAV; Ramasawmy R; Lopes SCP; Siqueira AM; Costa GL; Sousa TN; Vieira JLF; Lacerda MVG; Monteiro WM; de Melo GC
    Malar J; 2018 Jul; 17(1):267. PubMed ID: 30012145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.
    Melo GC; Monteiro WM; Siqueira AM; Silva SR; Magalhães BM; Alencar AC; Kuehn A; del Portillo HA; Fernandez-Becerra C; Lacerda MV
    PLoS One; 2014; 9(8):e105922. PubMed ID: 25157811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.
    Kittichai V; Nguitragool W; Ngassa Mbenda HG; Sattabongkot J; Cui L
    Infect Genet Evol; 2018 Oct; 64():168-177. PubMed ID: 29936038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates.
    Muhamad P; Chacharoenkul W; Rungsihirunrat K; Ruengweerayut R; Na-Bangchang K
    Asian Pac J Trop Biomed; 2011 Jan; 1(1):49-53. PubMed ID: 23569724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Origins of Mutations in the mdr1 Gene--A Putative Marker of Chloroquine Resistance in P. vivax.
    Schousboe ML; Ranjitkar S; Rajakaruna RS; Amerasinghe PH; Morales F; Pearce R; Ord R; Leslie T; Rowland M; Gadalla NB; Konradsen F; Bygbjerg IC; Roper C; Alifrangis M
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004196. PubMed ID: 26539821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
    Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014.
    Tantiamornkul K; Pumpaibool T; Piriyapongsa J; Culleton R; Lek-Uthai U
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):229-237. PubMed ID: 29677637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular surveillance of chloroquine resistance in Plasmodium vivax isolates from malaria cases in Yunnan Province of China using pvcrt-o gene polymorphisms.
    Ding H; Dong Y; Deng Y; Xu Y; Liu Y; Wu J; Chen M; Zhang C; Liu L; Lin Y
    Malar J; 2023 Nov; 22(1):338. PubMed ID: 37940956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel.
    Chung DI; Jeong S; Dinzouna-Boutamba SD; Yang HW; Yeo SG; Hong Y; Goo YK
    Malar J; 2015 Sep; 14():336. PubMed ID: 26337571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
    Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.
    Muhamad P; Ruengweerayut R; Chacharoenkul W; Rungsihirunrat K; Na-Bangchang K
    Malar J; 2011 Feb; 10():44. PubMed ID: 21324161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.
    Kim YK; Kim C; Park I; Kim HY; Choi JY; Kim JM
    Am J Trop Med Hyg; 2011 Apr; 84(4):532-4. PubMed ID: 21460004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.
    Gomes LR; Almeida-de-Oliveira NK; de Lavigne AR; de Lima SR; de Pina-Costa A; Brasil P; Daniel-Ribeiro CT; Ménard D; Ferreira-da-Cruz Mde F
    Malar J; 2016 Feb; 15():96. PubMed ID: 26887935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
    Fernández D; Segura C; Arboleda M; Garavito G; Blair S; Pabón A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6354-9. PubMed ID: 25114141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.
    Htun MW; Mon NCN; Aye KM; Hlaing CM; Kyaw MP; Handayuni I; Trimarsanto H; Bustos D; Ringwald P; Price RN; Auburn S; Thriemer K
    Malar J; 2017 Jul; 16(1):281. PubMed ID: 28693552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.
    Suwanarusk R; Russell B; Ong A; Sriprawat K; Chu CS; PyaePhyo A; Malleret B; Nosten F; Renia L
    J Antimicrob Chemother; 2015 Jan; 70(1):124-9. PubMed ID: 25150147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).
    Nyunt MH; Han JH; Wang B; Aye KM; Aye KH; Lee SK; Htut Y; Kyaw MP; Han KT; Han ET
    Malar J; 2017 Mar; 16(1):117. PubMed ID: 28298235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China.
    Lu F; Wang B; Cao J; Sattabongkot J; Zhou H; Zhu G; Kim K; Gao Q; Han ET
    Korean J Parasitol; 2012 Dec; 50(4):379-84. PubMed ID: 23230341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating
    Manh ND; Thanh NV; Quang HH; Van NTT; San NN; Phong NC; Birrell GW; Edgel KA; Martin NJ; Edstein MD; Chavchich M
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0004424. PubMed ID: 39046237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.